Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
Saved in:
| Title: | Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine. |
|---|---|
| Authors: | WENGER, KATHARINA J.1,2, BURGER, MICHAEL C.1,2, VOSS, MARTIN1,2, RONELLENFITSCH, MICHAEL W.1,2, STEINBACH, JOACHIM P.1,2, BÄHR, OLIVER1,2, WAGNER, MARLIES1,3, SE‑JONG YOU1,3, FRANZ, KEA1,4, HARTER, PATRICK N.1,5, FOKAS, EMMANOUIL1,6 |
| Source: | Oncology Letters. Jul2017, Vol. 14 Issue 1, p1141-1146. 6p. 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 123632517 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22WENGER%2C+KATHARINA+J%2E%22">WENGER, KATHARINA J.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22BURGER%2C+MICHAEL+C%2E%22">BURGER, MICHAEL C.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22VOSS%2C+MARTIN%22">VOSS, MARTIN</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22RONELLENFITSCH%2C+MICHAEL+W%2E%22">RONELLENFITSCH, MICHAEL W.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22STEINBACH%2C+JOACHIM+P%2E%22">STEINBACH, JOACHIM P.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22BÄHR%2C+OLIVER%22">BÄHR, OLIVER</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22WAGNER%2C+MARLIES%22">WAGNER, MARLIES</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22SE‑JONG+YOU%22">SE‑JONG YOU</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22FRANZ%2C+KEA%22">FRANZ, KEA</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22HARTER%2C+PATRICK+N%2E%22">HARTER, PATRICK N.</searchLink><relatesTo>1,5</relatesTo><br /><searchLink fieldCode="AR" term="%22FOKAS%2C+EMMANOUIL%22">FOKAS, EMMANOUIL</searchLink><relatesTo>1,6</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Oncology+Letters%22">Oncology Letters</searchLink>. Jul2017, Vol. 14 Issue 1, p1141-1146. 6p. 2 Charts, 2 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=123632517 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3892/ol.2017.6251 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1141 Titles: – TitleFull: Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: WENGER, KATHARINA J. – PersonEntity: Name: NameFull: BURGER, MICHAEL C. – PersonEntity: Name: NameFull: VOSS, MARTIN – PersonEntity: Name: NameFull: RONELLENFITSCH, MICHAEL W. – PersonEntity: Name: NameFull: STEINBACH, JOACHIM P. – PersonEntity: Name: NameFull: BÄHR, OLIVER – PersonEntity: Name: NameFull: WAGNER, MARLIES – PersonEntity: Name: NameFull: SE‑JONG YOU – PersonEntity: Name: NameFull: FRANZ, KEA – PersonEntity: Name: NameFull: HARTER, PATRICK N. – PersonEntity: Name: NameFull: FOKAS, EMMANOUIL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 17921074 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Oncology Letters Type: main |
| ResultId | 1 |
